merck kgaa (MRK:XETRA)
Member of Supervisory Board and Chairman of Research & Development Committee, Merck KGaA
|Age||Total Calculated Compensation||This person is connected to 35 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Helga Rubsamen-Schaeff served as the Managing Director and Chief Executive Officer at AiCuris GmbH & Co. KG, Wuppertal since 2006. Dr. Rubsamen-Schaeff was responsible, among other things, for securing a licensing deal with US pharmaceutical company Merck with a total value of up to EUR 442 million plus royalties. From 1994 to 2006, she held senior research positions at Bayer AG, Leverkusen, first as Vice President and Head of Antiviral Research from 1994 to 2001, ...
Frankfurter Strasse 250Phone: 49 6151 72 0
Darmstadt, Hessen 64293
Fax: 49 6151 72 5577
Board Members Memberships*
Member of The Board of Partners
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Ton Buchner||Chairman of Management Board and Chief Executive Officer|
Akzo Nobel NV
|Jean-Pierre Clamadieu||Chief Executive Officer, Director and Member of Finance Committee|
|Robert J. MacLeod||Chief Executive, Executive Director and Member of Chief Executive's Committee|
Johnson Matthey Plc
|Jean-Christophe Tellier||Chief Executive Officer and Executive Director|
|Torgeir Kvidal||Acting Chief Executive Officer and Acting President|
Yara International ASA
|4.3M NOK||Compensation as of Fiscal Year 2014.|